Friday, January 21, 2022
wellness India Expo
Home Tags Drug

Tag: drug

New study by BHU scientists raises prospect of Zika virus therapy

A team of researchers has found that the virus interacts with a set of cells called microglial cells, which protect the brain from infections and that a protein in the virus called ZIKV-NS1 plays an important role in its replication and immune evasion

CSIR-CDRI transfers tech to Marc Labs, aims to develop safer drug...

Central Drug Research Institute has recently obtained the permission to initiate the Phase I clinical trials for the new safer drug for heart attack and stroke expected to be in the market soon

Dr. Srivari Chandrasekhar takes charge as the new DST secretary

Before heading Department of Science and Technology, Dr. Chandrashekhar was until recently Director of CSIR’s Indian Institute of Chemical Technology (IICT) at Hyderabad

Zydus gets go ahead for phase-2 clinical trial of its novel...

The company will soon begin the Phase II (a) clinical trial of ZYIL1, a novel oral NLRP3 inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome (CAPS), a rare life-long auto-inflammatory condition in Australia

Monoclonal antibody therapy prevents severe Covid-19 deaths: AIG Hospitals’ study

Study conducted on 285 high-risk individuals and published in the International Journal of Internal Medicine successfully proved that the Monoclonal Therapy reduces severe disease and death in high-risk individuals infected with the Delta Variant of SARS CoV 2...................

Top 5 pharma majors collaborate to conduct clinical trial of anti-viral...

Cipla, Dr. Reddy’s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19...........................

New drug for coronary diseases could be in offing

An agreement between CSIR-CDRI and Marc Laboratories could pave the way for developing a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen-induced platelet aggregation....................

Biotech startup, CyGenica secures USD $1.4 million funding from SOSV

The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug delivery.............................

Cipla signs COVID-19 drug licensing deal with MSD

Cipla enters into a licensing agreement with MSD to expand access to the investigational oral therapeutic drug for COVID-19 treatment...........................

Mankind Pharma seeks CDSCO’s nod to conduct phase-1 clinical trials of...

A patented first in class novel anti-diabetic molecule, MKP10241 is a potent and orally administered small molecule, GPR119 agonist.........................